 |
|
| Blog results | Results 1 - 10 of about 386 for abbott biaxin xl. (0.25 seconds) |
| Sorted by relevance Sort by date |
| 6 Aug 2006 by Aaron Barkoff by David Harper Abbott Laboratories and Teva Pharmaceuticals have settled their Biaxin XL patent infringement litigation in the US District Court for the Northern District of Illinois. Biaxin XL is an extended release formulation of ... Orange Book Blog - http://www.orangebookblog.com/ - References [ More results from Orange Book Blog ] |
| 11 Sep 2009 by WHY??? newly ap-proved d-rug therapie,s (28+) clarithromycin -(biaxi*n), abbott .... + order levaquin_ cheap pric,es get 12. free pi.lls f+or orders o'ver $300. .buy ethionamid+e. in denver - jzi-p forum_ b*ioportfolio - te*rramy,cin ... WHY??? - http://antistupido.blogspot.com/ |
| 8 Jan 2007 by HSA by aaron f. barkoff abbott labs ((abt) is fending off multiple generic challenges to biaxin xl (clarithromycin extended-release tablets), an antibiotic with annual sales of over $300 million in the united states. ... biohealth Investor - http://biohealthinvestor.com/ - References [ More results from biohealth Investor ] |
| 24 Oct 2008 by admin oct. 21 (bloomberg) — novartis ag 's sandoz unit lost its bid to begin selling generic versions of the abbott laboratories antibiotic biaxin xl before a trial on a patent dispute over the medicine. Sales Leads for FREE - http://www.salesleads4free.com/ [ More results from Sales Leads for FREE ] |
| 2 Feb 2009 BIAXIN XL Filmtab (clarithromycin extended-release tablets) are supplied as yellow oval film-coated 500 mg tablets debossed (on one side) with the Abbott logo and a two-letter Abbo-Code designation, KJ in the following packaging sizes: ... RxList - News and Features - http://www.rxlist.com/script/main/hp.asp - References |
| 28 Oct 2008 a federal appeals court upheld a preliminary injunction barring sandoz from selling a generic version of abbott laboratories' extended-release antibiotic biaxin. fdanews Drug Daily Bulletin - http://www.fdanews.com/ |
| 18 Jul 2007 by david.donoghue@dlapiper.com (R. David Donoghue) abbott laboratories and andrx pharmaceuticals have settled their northern district patent litigation over andrx's efforts to sell a generic version of abbott's extended release antibiotic biaxin xl, case no.05 c 1490 (discussed at ... Chicago IP Litigation Blog - http://www.chicagoiplitigation.com/ [ More results from Chicago IP Litigation Blog ] |
| 3 Jan 2008 watson pharmaceutical launches generic of abbott's biaxin xlcnnmoney.com - 58 minutes ago. read more. orangemed.com News - Medical News You Need - http://www.orangemed.com/news/ |
| 9 Jan 2007 by Donald Zuhn Abbott sued Andrx Pharmaceuticals, Inc, Ranbaxy Laboratories, Inc., and Teva Pharmaceuticals USA, Inc. for ANDA filings with the FDA for generic versions of Abbott's Biaxin XL, an extended release formulation of the antibiotic ... Patent Docs - http://patentdocs.typepad.com/patent_docs/ [ More results from Patent Docs ] |
| 3 Jan 2008 by Dr. DK S watson's clarithromycin extended-release product is the generic equivalent to abbott's biaxin(r) xl, which is indicated to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ... ippharm Doc - http://ippharmdoc.blogspot.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
